Cabeza MR, Leis V, Silvente C, Mauleón C, Suárez R, Lázaro P

Language: Spanish
References: 15
Page: 298-301
PDF size: 215.04 Kb.

ABSTRACT

The fibromatoses are slow-growing fibrous tumors that spread to local invasion, without producing metastases and with postoperative recurrence. The ethiology and the mechanisms of formation have not been fully determined. Palmar-plantar fibromatosis has been associated with smoking, alcoholic liver disease, Diabetes and seizure disorders. The diagnosis is clinical with appearance of firm nodules or tumors like cords following the tendons. MR imaging is useful for diagnosis and has become valuablein planning surgical treatment.

REFERENCES

1. Bolognia JL, Jorizzo JL, Rapini R.P.Dermatología. 1ª ed. Madrid. Elsevier España S.A. 2004:1874-75.

2. Mark R. Robbin, Mark D. Murphey, H. Thomas Temple, Mark J. Kransdorf, and James J. Choi. Imaging of Musculo skeletal Fibromatosis. Radiographics2001;21:585-600.

3. Ross DC. Epidemiology of Dupuytren’s disease. Hand Clin1999;15:53-62.

4. Wilbrand S, Ekbom A, Gerdin B: The sex ratio and rate of reoperation for Dupuytren’s contracture in men and women. J Hand Surg [Br] 1999; 24:456-9.

5. Gudmundsson KG, Arngrimsson R, Sigfusson N, Bjornsson A, Jonsson T. Epidemiology of Dupuytren´s disease: clinical, serolo-gical, and social assessment. The Reykjavik Study. J Clin Epidemiol 2000;53:291-6.

6. Magro G, Lanteri E, Micali G, Paravizzini G, Travali S, Lanzafame S. Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor. J Pathol 1997;181:213-7.

7. Varallo VM, Gan Bs, Seney S, Ross DC, Roth JH, Richards RS, McFarlane RM, Alman B,Howard JC. Beta-catenin expression in Dupuytren´s disease: potential role for cell-matrix inter-actions in modulating beta-catenin levels in vivoand in vitro. Oncogene 2003;22:3680-4.

8. Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol 2001;14:695-701.

9. Kozma EM, Olczyk, Wisowski G, Glowacki A, Bobinski R. Alterations in the extracellular matrix proteoglycan profile in Dupuytren’s contracture affect the palmar fascia. J Biochem 2005;137:463-76.

10. Ulrich D, Hrynyschyn K, Pallua N. Matrixmetallo proteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren´s disease. Plast Reconstr Surg 2003;112:1279-86.

11. Weedon D. Piel Patología. Madrid. Marbán. 2002:762.

12. Fetsch JF, Laskin WB, Miettinen M. Palmar-plantar fibromatosis in children and preadolescents: a clinico pathologic study of 56cases with newly recognized demographics and extended follow-up information. Am JSurg Pathol 2005;29:1095-105.

13. Skoff HD. The surgical treatment of Dupuytren´s contracture: a synthesis of techniques. Plast Reconstr Surg 2004;113:540-544.

14. De Bree E, Zoetmulder FAN, Keus RB, et al. Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg 2004;187:33-38.

15. Gudmundsson KG, Arngrimsson R, Jonsson T. Eighteen years of follow-up study of the clinical manifestations and progression of Duputren’s disease. Scand J Rheumatol 2001;30:31-34.